Cambridge Research Biochemicals


Latest news from CRB

September 2012
In This Issue…

3 September 2012: AssayMetrics and Cambridge Research Biochemicals collaborate in the field of Fluorescence Lifetime technology
6 July 2012: Cambridge Research Biochemicals signs deal with LI-COR Biosciences
11 May 2012: RCUK Shared Service Centre Ltd extends contract with Cambridge Research Biochemicals
27 March 2012: Cambridge Research Biochemicals signs exclusive Japanese distribution deal with BioBridge
 
03
Sep
12
AssayMetrics and Cambridge Research Biochemicals collaborate in the field of Fluorescence Lifetime Technology
AssayMetrics Ltd, a Discovery Tools company, is pleased to announce collaboration with Cambridge Research Biochemicals (CRB) the UK's most established peptide and antibody company.

Fluorescence Lifetime is a new and ground-breaking assay technology used in the biochemical screening of new drugs in High Throughput Screening and compound characterisation roles in the pharmaceutical industry.

The collaboration involves Cambridge Research Biochemicals making key peptide substrates labelled with AssayMetrics' Fluorescence Lifetime dyes. The peptides are used to screen novel drugs in equipment such as AssayMetrics' Fluospec® FL reader and are employed in assays involving kinases, proteases, protein:protein interactions and other target enzyme systems.
 
news-image-one
AssayMetric's Fluospec® plate reader
Read More on this story... Assay Metrics Ltd.
06
Jul
12
Cambridge Research Biochemicals Signs Deal with LI-COR Biosciences for Infrared Dye Labelled
Cleveland, UK: Leading research peptide manufacturer, Cambridge Research Biochemicals (CRB), announced today that it has signed a non-exclusive license with LI-COR Biosciences (LI-COR) to develop, manufacture and sell IRDye® and IRDye® QC-1 near-infrared dye-labelled peptides for research use only.

CRB is a world leader in providing dye labelled products to researchers. The partnership with LI-COR will enable the company to provide dye labelled peptides, which are unique in the field of fluorescence imaging applications.

LI-COR has been developing high-quality near-infrared technology for the life science research community for more than twenty years. LI-COR products support many applications, including quantitative Western blot detection, In-Cell Western™ assays, EMSAs, FLISA, protein assays, florescence microscopy, tissue sections and in-vivo imaging.
 
news-image-one
In vivo imaging
Read More on this story... Li-Cor. 
11
May
12
RCUK Shared Services Centre Ltd extends contract with Cambridge Research Biochemicals
Cambridge Research Biochemicals (CRB), announced today that it has extended its contract with RCUK Shared Services Centre Ltd (RCUK SSC Ltd) to supply custom synthesised peptides and custom generated polyclonal and monoclonal antibodies for a further 12 months.

CRB Commercial Director, Emily Humphrys commented,"We are delighted with the extension of this contract which demonstrates our strong performance over the last two years in providing high quality research peptide and antibody tools. As a company we are recognised for constantly reaching the high technical and service standards required by the Research Councils. This agreement is an acknowledgement of the value of our focus on quality and innovation in the production of speciality research peptides and antibodies brings to our clients."
Read More on this story... Shared Services Centre. 
27
Mar
12
Cambridge Research Biochemicals Signs Exclusive Japanese Distribution Deal with BioBridge
Leading research peptide manufacturer, Cambridge Research Biochemicals (CRB) announced today that it will be expanding its business into Asia through the signing of an exclusive deal with BioBridge. BioBridge will be responsible for the sales and marketing of CRB's custom services in Japan.

This agreement is one of a series that has seen CRB continuing to grow through the wider economic difficulties of the last two years by increasing market share in existing territories and penetrating new overseas markets within Europe, North America and now Asia. The company is hoping to continue its expansion programme into other Asian markets through similar types of exclusive partnerships.
 
news-image-one
BioBridge partnership to help expansion in Asian market
Read More on this story... BioBridge
www.crbdiscovery.com
T +44 (0)1642 567180
F +44 (0)1642 567181
E enquiries@crbdiscovery.com

17-18 Belasis Court, Belasis Hall Technology Park, Billingham, Cleveland, TS23 4AZ, United Kingdom